Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
作者信息
Gundersen S, Monfardini S, Renard G, Van Glabbeke M, Pinedo H
机构信息
Det Norske Radiumhospital, Oslo, Norway.
出版信息
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1707-8. doi: 10.1016/0277-5379(87)90454-8.
PMID:2962875
Abstract
摘要
相似文献
1
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.美诺加 ril 治疗晚期恶性黑色素瘤的 II 期试验。一项欧洲癌症研究与治疗组织（EORTC）的试验。
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1707-8. doi: 10.1016/0277-5379(87)90454-8.
2
Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.静脉注射美诺加 ril 治疗晚期卵巢癌的 II 期研究。欧洲癌症研究与治疗组织早期临床试验组。
Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9.
3
4
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.美诺加（menogaril）用于晚期肺鳞癌、腺癌和大细胞癌的II期阴性试验。
Eur J Cancer Clin Oncol. 1988 Feb;24(2):263-5. doi: 10.1016/0277-5379(88)90263-5.
5
Phase II study of intravenous menogaril in patients with advanced breast cancer.静脉注射美诺加ril治疗晚期乳腺癌患者的II期研究。
J Natl Cancer Inst. 1988 Sep 7;80(13):1066-9. doi: 10.1093/jnci/80.13.1066.
6
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.美诺加 ril 治疗胰腺腺癌的 II 期试验。西南肿瘤协作组的一项研究。
Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550.
7
Phase II trial of menogaril in advanced colorectal cancer.美诺加 ril 用于晚期结直肠癌的 II 期试验。
Invest New Drugs. 1988 Sep;6(3):227-30. doi: 10.1007/BF00175404.
8
Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Cancer Treat Rep. 1987 Sep;71(9):871-2.
9
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.美诺加里尔每日间歇输注5天的I期试验。
Cancer Treat Rep. 1986 Jun;70(6):721-5.
10
Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.美诺加明静脉持续输注72小时的I期和药代动力学研究。
Cancer Treat Rep. 1987 Jun;71(6):593-8.
Zotero 插件